Healthcare provider profile · identity verified

Caroline Tahara, MD

Internal Medicine · WHITE BEAR LAKE, MN · NPI 1669446423

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	888	239
Amlodipine Besylate	Amlodipine Besylate	591	162
Levothyroxine Sodium	Levothyroxine Sodium	530	142
Lisinopril	Lisinopril	525	146
Metoprolol Succinate	Metoprolol Succinate	327	91
Losartan Potassium	Losartan Potassium	323	93
Hydrochlorothiazide	Hydrochlorothiazide	321	89
Simvastatin	Simvastatin	286	78
Omeprazole	Omeprazole	278	88
Gabapentin	Gabapentin	204	64
Metformin Hcl Er	Metformin Hcl	186	53
Sertraline Hcl	Sertraline Hcl	167	49
Eliquis	Apixaban	148	38
Ozempic	Semaglutide	145	26
Trazodone Hcl	Trazodone Hcl	141	49
Rosuvastatin Calcium	Rosuvastatin Calcium	139	46
Atenolol	Atenolol	137	38
Famotidine	Famotidine	127	42
Alendronate Sodium	Alendronate Sodium	110	34
Escitalopram Oxalate	Escitalopram Oxalate	109	31
Fluticasone Propionate	Fluticasone Propionate	103	44
Furosemide	Furosemide	102	36
Citalopram Hbr	Citalopram Hydrobromide	92	25
Warfarin Sodium	Warfarin Sodium	87	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	23
Bupropion Xl	Bupropion Hcl	84	29
Duloxetine Hcl	Duloxetine Hcl	82	24
Metformin Hcl	Metformin Hcl	80	21
Glipizide Er	Glipizide	74	21
Pravastatin Sodium	Pravastatin Sodium	70	20
Spironolactone	Spironolactone	66	19
Potassium Chloride	Potassium Chloride	65	19
Trulicity	Dulaglutide	63	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	60	19
Irbesartan	Irbesartan	59	18
Allopurinol	Allopurinol	58	19
Jardiance	Empagliflozin	56	15
Terazosin Hcl	Terazosin Hcl	55	15
Xarelto	Rivaroxaban	55	14
Pantoprazole Sodium	Pantoprazole Sodium	54	14
Albuterol Sulfate Hfa	Albuterol Sulfate	51	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	15
Synthroid	Levothyroxine Sodium	50	12
Estradiol	Estradiol	49	21
Metoprolol Tartrate	Metoprolol Tartrate	47	13
Carvedilol	Carvedilol	46	16
Lansoprazole	Lansoprazole	42	suppressed
Solifenacin Succinate	Solifenacin Succinate	40	14
Acyclovir	Acyclovir	39	18
Clopidogrel	Clopidogrel Bisulfate	39	13
Triamcinolone Acetonide	Triamcinolone Acetonide	39	24
Mounjaro	Tirzepatide	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	13
Risedronate Sodium	Risedronate Sodium	36	13
Propranolol Hcl	Propranolol Hcl	35	suppressed
Alprazolam	Alprazolam	34	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Lorazepam	Lorazepam	34	14
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Tramadol Hcl	Tramadol Hcl	32	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	11
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Baclofen	Baclofen	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Ondansetron Odt	Ondansetron	24	13
Ketoconazole	Ketoconazole	23	11
Mirtazapine	Mirtazapine	23	suppressed
Prednisone	Prednisone	23	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Pregabalin	Pregabalin	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	11
Hydrocortisone	Hydrocortisone	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Nitroglycerin	Nitroglycerin	17	13
Pilocarpine Hcl	Pilocarpine Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Tradjenta	Linagliptin	14	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Nystatin	Nystatin	13	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Armodafinil	Armodafinil	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error